secwatch.observer — SEC 8-K summary
======================================

Issuer:     Senti Biosciences, Inc. (SNTI)
CIK:        0001854270
Form:       8-K
Filed at:   2026-05-26T20:02:21+00:00
Accession:  0001628280-26-038058
Event type: debt
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Senti Biosciences issues $10M convertible notes to Celadon; discloses potential merger with $60M CVR
--------------------------------------------------------------------------------

- $10M senior secured convertible notes sold to Celadon Partners; maturity 6 months, 12% default interest rate on event of default.
- Notes convertible into common stock; mandatory exchange upon stockholder approval or CVR closing.
- Potential transaction: Celadon affiliate to merge into Senti Holdings and issue CVR up to $60M tied to SENTI-202 milestones.
- Company to file proxy statement for stockholder vote on potential merger and CVR issuance.
- Registration rights, guarantee, and voting agreements also entered with directors and Celadon.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1854270/000162828026038058/0001628280-26-038058-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1854270/000162828026038058/snti-20260520.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-038058

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer